nodes	percent_of_prediction	percent_of_DWPC	metapath
Stanozolol—AR—obesity	0.93	1	CbGaD
Stanozolol—AR—Nongenotropic Androgen signaling—SHBG—obesity	0.00304	0.0508	CbGpPWpGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—KDM3A—obesity	0.00275	0.0459	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—SFTPA2—obesity	0.0027	0.0452	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—PPARD—obesity	0.00192	0.032	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—NR1I3—obesity	0.00175	0.0292	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—NR1I2—obesity	0.0016	0.0267	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—PPARD—obesity	0.00151	0.0253	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—NR1I3—obesity	0.00138	0.0231	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—NR0B2—obesity	0.00138	0.0231	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYOG—obesity	0.00127	0.0212	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—NR1I2—obesity	0.00126	0.0211	CbGpPWpGaD
Stanozolol—AR—Notch-mediated HES/HEY network—MYOD1—obesity	0.0012	0.0201	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—ESR2—obesity	0.000949	0.0159	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—NR0B2—obesity	0.000883	0.0148	CbGpPWpGaD
Stanozolol—Oxandrolone—AR—obesity	0.000879	0.084	CrCbGaD
Stanozolol—AR—Notch-mediated HES/HEY network—PARP1—obesity	0.000846	0.0141	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—GCG—obesity	0.000815	0.0136	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—MYOD1—obesity	0.000777	0.013	CbGpPWpGaD
Stanozolol—Trilostane—ESR2—obesity	0.000767	0.0733	CrCbGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—ESR2—obesity	0.00075	0.0125	CbGpPWpGaD
Stanozolol—AR—Notch-mediated HES/HEY network—NCOA1—obesity	0.000738	0.0123	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—FTL—obesity	0.00071	0.0119	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—ACADM—obesity	0.0007	0.0117	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—NR3C1—obesity	0.000678	0.0113	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—NCOA1—obesity	0.00067	0.0112	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—APOB—obesity	0.00067	0.0112	CbGpPWpGaD
Stanozolol—Drostanolone—SHBG—obesity	0.000667	0.0638	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—SLC9A3—obesity	0.000663	0.0111	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—PPARA—obesity	0.000636	0.0106	CbGpPWpGaD
Stanozolol—Danazol—CCL2—obesity	0.000633	0.0605	CrCbGaD
Stanozolol—AR—Regulation of Androgen receptor activity—SIRT1—obesity	0.000586	0.00979	CbGpPWpGaD
Stanozolol—Drostanolone—AR—obesity	0.000585	0.0559	CrCbGaD
Stanozolol—AR—Nuclear Receptors—ESR1—obesity	0.000576	0.00962	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—FOXO1—obesity	0.000547	0.00915	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—PPARGC1B—obesity	0.000546	0.00913	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—NR3C1—obesity	0.000536	0.00896	CbGpPWpGaD
Stanozolol—AR—Nongenotropic Androgen signaling—PIK3R1—obesity	0.000532	0.00889	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—PPARG—obesity	0.000525	0.00878	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—NR3C1—obesity	0.00052	0.00869	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L2—obesity	0.000514	0.00859	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—ESR1—obesity	0.000512	0.00856	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—PPARA—obesity	0.000502	0.0084	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—HDAC8—obesity	0.000497	0.0083	CbGpPWpGaD
Stanozolol—Drostanolone—CYP19A1—obesity	0.00049	0.0468	CrCbGaD
Stanozolol—Testosterone Propionate—COMT—obesity	0.000478	0.0457	CrCbGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—NCOA1—obesity	0.000477	0.00798	CbGpPWpGaD
Stanozolol—Trilostane—ESR1—obesity	0.000472	0.0452	CrCbGaD
Stanozolol—AR—FOXA1 transcription factor network—INS—obesity	0.000458	0.00766	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—ESR1—obesity	0.000455	0.00761	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—FOXO3—obesity	0.000454	0.00759	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—NCOA1—obesity	0.000443	0.0074	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—PPARG—obesity	0.000415	0.00694	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—PRKAR2B—obesity	0.000405	0.00677	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—IL10—obesity	0.0004	0.00669	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—CPT1A—obesity	0.000391	0.00653	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—FOXO1—obesity	0.00039	0.00652	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—SIRT1—obesity	0.000387	0.00647	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—GCK—obesity	0.000381	0.00637	CbGpPWpGaD
Stanozolol—Fluoxymesterone—SHBG—obesity	0.000377	0.036	CrCbGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—obesity	0.00037	0.00619	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—TF—obesity	0.000363	0.00607	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—FOXO1—obesity	0.000362	0.00604	CbGpPWpGaD
Stanozolol—Danazol—SHBG—obesity	0.00036	0.0344	CrCbGaD
Stanozolol—Testosterone Propionate—AR—obesity	0.000357	0.0341	CrCbGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—CST3—obesity	0.000344	0.00575	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000342	0.00571	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—NTRK2—obesity	0.000332	0.00556	CbGpPWpGaD
Stanozolol—Fluoxymesterone—AR—obesity	0.000331	0.0316	CrCbGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—obesity	0.000324	0.00542	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—IAPP—obesity	0.000322	0.00538	CbGpPWpGaD
Stanozolol—Norethindrone—SHBG—obesity	0.00032	0.0306	CrCbGaD
Stanozolol—Danazol—AR—obesity	0.000316	0.0302	CrCbGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—obesity	0.000314	0.00525	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—ESR2—obesity	0.000307	0.00513	CbGpPWpGaD
Stanozolol—Methyltestosterone—SHBG—obesity	0.000304	0.0291	CrCbGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—CDKN2A—obesity	0.000303	0.00506	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—CAV1—obesity	0.000302	0.00506	CbGpPWpGaD
Stanozolol—AR—Nongenotropic Androgen signaling—PIK3CA—obesity	0.000299	0.005	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—STK11—obesity	0.000286	0.00478	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—CYP19A1—obesity	0.000286	0.00478	CbGpPWpGaD
Stanozolol—AR—Notch-mediated HES/HEY network—STAT3—obesity	0.000272	0.00454	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—MAPK8—obesity	0.00027	0.00452	CbGpPWpGaD
Stanozolol—Methyltestosterone—AR—obesity	0.000267	0.0255	CrCbGaD
Stanozolol—Danazol—CYP19A1—obesity	0.000264	0.0253	CrCbGaD
Stanozolol—AR—Gene Expression—APOBEC1—obesity	0.000264	0.00441	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—PPARD—obesity	0.000262	0.00437	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—ESR2—obesity	0.000261	0.00436	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—obesity	0.000258	0.00432	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—GNB3—obesity	0.000255	0.00427	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.000255	0.00427	CbGpPWpGaD
Stanozolol—Fluoxymesterone—ESR1—obesity	0.000255	0.0243	CrCbGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—SIRT1—obesity	0.000254	0.00424	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—BDNF—obesity	0.000248	0.00415	CbGpPWpGaD
Stanozolol—AR—Nongenotropic Androgen signaling—AKT1—obesity	0.000244	0.00409	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—obesity	0.000244	0.00407	CbGpPWpGaD
Stanozolol—Danazol—ESR1—obesity	0.000243	0.0233	CrCbGaD
Stanozolol—AR—Generic Transcription Pathway—NR1I3—obesity	0.000238	0.00398	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—NR0B2—obesity	0.000238	0.00398	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—STK11—obesity	0.000237	0.00396	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—FOXO1—obesity	0.000237	0.00396	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL10—obesity	0.000237	0.00396	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—RHOA—obesity	0.000231	0.00386	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—PIK3R1—obesity	0.000229	0.00382	CbGpPWpGaD
Stanozolol—Fluoxymesterone—NR3C1—obesity	0.000224	0.0214	CrCbGaD
Stanozolol—Methyltestosterone—CYP19A1—obesity	0.000223	0.0214	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—NR3C1—obesity	0.000219	0.00366	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—NR1I2—obesity	0.000218	0.00364	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—BDNF—obesity	0.000211	0.00353	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—SIRT1—obesity	0.00021	0.00351	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—HTR2A—obesity	0.00021	0.0035	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—obesity	0.0002	0.00334	CbGpPWpGaD
Stanozolol—AR—Gene Expression—CTNNBL1—obesity	0.0002	0.00334	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—ESR1—obesity	0.000191	0.00319	CbGpPWpGaD
Stanozolol—Progesterone—SHBG—obesity	0.000187	0.0179	CrCbGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—BAD—obesity	0.000186	0.00312	CbGpPWpGaD
Stanozolol—Progesterone—SLC22A1—obesity	0.000184	0.0176	CrCbGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—IRS1—obesity	0.000178	0.00298	CbGpPWpGaD
Stanozolol—Testosterone—SHBG—obesity	0.000177	0.0169	CrCbGaD
Stanozolol—Testosterone—SLC22A1—obesity	0.000174	0.0167	CrCbGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—obesity	0.000165	0.00276	CbGpPWpGaD
Stanozolol—Progesterone—AR—obesity	0.000164	0.0157	CrCbGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—MYC—obesity	0.000163	0.00273	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—STAT3—obesity	0.000163	0.00273	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—ESR1—obesity	0.000158	0.00264	CbGpPWpGaD
Stanozolol—Testosterone—AR—obesity	0.000155	0.0148	CrCbGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—BAD—obesity	0.000154	0.00258	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—BCL2—obesity	0.000144	0.00241	CbGpPWpGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—AKT1—obesity	0.000142	0.00238	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—MTOR—obesity	0.000138	0.00231	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—IGF1—obesity	0.000137	0.00229	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—PARP1—obesity	0.000137	0.00229	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—ESR2—obesity	0.00013	0.00217	CbGpPWpGaD
Stanozolol—Testosterone—CYP19A1—obesity	0.00013	0.0124	CrCbGaD
Stanozolol—Progesterone—ESR1—obesity	0.000126	0.0121	CrCbGaD
Stanozolol—AR—Gene Expression—PPARD—obesity	0.000126	0.00211	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL1B—obesity	0.000124	0.00208	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—BCL2—obesity	0.00012	0.002	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—NCOA1—obesity	0.000119	0.002	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NR0B2—obesity	0.000115	0.00192	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NR1I3—obesity	0.000115	0.00192	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—obesity	0.000114	0.0019	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	0.000113	0.00189	CbGpPWpGaD
Stanozolol—Progesterone—NR3C1—obesity	0.000111	0.0106	CrCbGaD
Stanozolol—AR—Androgen receptor signaling pathway—AKT1—obesity	0.000105	0.00176	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NR1I2—obesity	0.000105	0.00175	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—MYC—obesity	9.93e-05	0.00166	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	9.69e-05	0.00162	CbGpPWpGaD
Stanozolol—Norethindrone—ALB—obesity	9.64e-05	0.00921	CrCbGaD
Stanozolol—AR—Generic Transcription Pathway—NR3C1—obesity	9.26e-05	0.00155	CbGpPWpGaD
Stanozolol—Methyltestosterone—ALB—obesity	9.15e-05	0.00875	CrCbGaD
Stanozolol—AR—SIDS Susceptibility Pathways—TNF—obesity	9.01e-05	0.00151	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—PPARA—obesity	8.67e-05	0.00145	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—MYC—obesity	8.23e-05	0.00138	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	8.21e-05	0.00137	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—ESR1—obesity	7.86e-05	0.00131	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—TNF—obesity	7.67e-05	0.00128	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL6—obesity	7.27e-05	0.00122	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—PPARG—obesity	7.17e-05	0.0012	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	6.99e-05	0.00117	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—AKT1—obesity	6.89e-05	0.00115	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PARP1—obesity	6.59e-05	0.0011	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—SERPINE1—obesity	6.46e-05	0.00108	CbGpPWpGaD
Stanozolol—AR—Gene Expression—ESR2—obesity	6.24e-05	0.00104	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NCOA1—obesity	5.75e-05	0.000961	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—AKT1—obesity	5.71e-05	0.000954	CbGpPWpGaD
Stanozolol—Testosterone—ALB—obesity	5.31e-05	0.00508	CrCbGaD
Stanozolol—AR—Gene Expression—SIRT1—obesity	5.02e-05	0.00084	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NR3C1—obesity	4.46e-05	0.000745	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PRKCD—obesity	4.36e-05	0.000728	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PPARA—obesity	4.18e-05	0.000698	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—MYC—obesity	4.09e-05	0.000683	CbGpPWpGaD
Stanozolol—AR—Gene Expression—ESR1—obesity	3.78e-05	0.000633	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PPARG—obesity	3.45e-05	0.000577	CbGpPWpGaD
Stanozolol—AR—Gene Expression—SERPINE1—obesity	3.11e-05	0.00052	CbGpPWpGaD
Stanozolol—AR—Gene Expression—MYC—obesity	1.97e-05	0.000329	CbGpPWpGaD
Stanozolol—AR—Gene Expression—AKT1—obesity	1.36e-05	0.000228	CbGpPWpGaD
